GILD

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

By Josh Enomoto, InvestorPlace Contributor
The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable. These seven stocks require caution.

2 Must-Own Biotech Stocks to Buy in May

By David Cohne, StockNews.com
After a stellar rally in 2020, biotech stocks have been selling off over the past couple of months. This offers investors a buying opportunity to scoop up quality biotech stocks at cheaper prices.

Vaccitech IPO: When Does Vaccitech Go Public? What Is the VACC Stock IPO Price Range?

By Chris MacDonald, InvestorPlace Contributor
The upcoming Vaccitech IPO is one I think investors will have their eye on, as speculators look for early stage biopharma plays today.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor
So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor
The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic

By Tezcan Gecgil, InvestorPlace Contributor
Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

7 Value Stocks Everyone Is Ignoring

By Tezcan Gecgil, InvestorPlace Contributor
Blue chips and companies on the rebound. Here are seven of the best value stocks for long-term investors.

7 High-Yield Stocks for Your Retirement Nest Egg

By Tom Taulli, InvestorPlace Contributor
High-dividend names are some of the best retirement stocks and can be a good way to achieve strong long-term growth for your portfolio.

3 Deep Value Stocks for Income and High Total Returns

By Bob Ciura, Sure Dividend
Look to these value stocks for a great blend of dividend safety, payout growth, current yield and capital appreciation potential.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor
Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

5 Undervalued Dividend Stocks to Buy

By Thomas Niel, InvestorPlace Contributor
With markets at record highs and interest rates at record lows, consider these five dividend stocks to buy for value and yield.

3 Cheap Stocks Worth Buying Right Now

By Chris Tyler, InvestorPlace Contributor
Cheap stocks can come with many caveats. But sometimes, and as these three companies shares point at, they come equipped with some real value.

Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand

By Josh Enomoto, InvestorPlace Contributor
As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.

4 Top Biotech Stocks to Buy for Operation Warp Speed

By Joel Baglole, InvestorPlace Contributor
The U.S. government has pulled out all the stops to develop a treatment for Covid-19. These biotech stocks are leading the race for a cure.

Which Biotech Stocks Are a Buy on Earnings?

By Louis Navellier, Editor, Growth Investor
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.

4 Top Stock Trades for Monday: TWLO, SNAP, SPAQ, GILD

By Bret Kenwell, InvestorPlace Contributor
Twilio, Gilead Sciences, Snap and Spartan Energy Acquisition are our top stock trades to watch on Monday. And here's why.

Gilead Stock: 12 Things for Investors to Know About Remdesivir Approval

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Want to know what the big remdesivir approval actually means for Gilead stock? Here's everything investors need to understand.

GILD News: Gilead Stock Pops as FDA Approves Remdesivir Treatment

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Gilead stock is climbing higher Thursday after its remdesivir coronavirus treatment received full approval from the FDA. Why it matters.

9 Stocks to Buy for a Wild Ride in November

By Josh Enomoto, InvestorPlace Contributor
With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.
Load More